Cargando…
Design and Synthesis of HCV-E2 Glycoprotein Epitope Mimics in Molecular Construction of Potential Synthetic Vaccines
Hepatitis C virus remains a global threat, despite the availability of highly effective direct-acting antiviral (DAA) drugs. With thousands of new infections annually, the need for a prophylactic vaccine is evident. However, traditional vaccine design has been unable to provide effective vaccines so...
Autores principales: | Meuleman, Theodorus J., Cowton, Vanessa M., Patel, Arvind H., Liskamp, Rob M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924389/ https://www.ncbi.nlm.nih.gov/pubmed/33672697 http://dx.doi.org/10.3390/v13020326 |
Ejemplares similares
-
Improving the aqueous solubility of HCV‐E2 glycoprotein epitope mimics by cyclization using POLAR hinges
por: Meuleman, Theodorus J., et al.
Publicado: (2020) -
Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design
por: Cowton, Vanessa M., et al.
Publicado: (2021) -
Predicting the Effectiveness of Hepatitis C Virus Neutralizing Antibodies by Bioinformatic Analysis of Conserved Epitope Residues Using Public Sequence Data
por: Cowton, Vanessa M., et al.
Publicado: (2018) -
Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus
por: Naik, Amruta S., et al.
Publicado: (2017) -
Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs
por: Jourdan, N., et al.
Publicado: (2006)